A carregar...
Publicação
Once we have it, will we use it?
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 837.36 KB | Adobe PDF |
Orientador(es)
Resumo(s)
While the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect against the disease COVID-19, policymakers should prepare for the next challenge: uptake of the vaccine among the public. Having a vaccine does not automatically imply it will be used. Compliance with the anti-H1N1 vaccine during the 2009 influenza pandemic, for instance, was low [1], and in the decade since, vaccination rates have remained an issue of concern [2] while vaccination hesitancy has become more prevalent, leading to increases in disease outbreaks in multiple countries [3]. It is, therefore, important to understand whether or not people are willing to be vaccinated against COVID-19, as this can have large consequences for the success a vaccination programme—with potentially large health and economic consequences. In this editorial, we provide some first insights into this willingness to be vaccinated, based on a multi-country European study [4], which hopefully result in more attention for this important issue.
Descrição
Funding text: European Union (EU) grant nr. 721402; Excellence Strategy by the German federal and state governments; University of Hamburg, Erasmus School of Health Policy Management; Nova School of Business and Economics Lisbon-Chair BPI | "Fundacao La Caixa" on Health Economics
Palavras-chave
SDG 3 - Good Health and Well-being